series-a
Stage
1
Investors
About
Cardiosense develops FDA-authorized, noninvasive cardiac monitoring hardware and AI technology that provides real-time measurement of Pulmonary Capillary Wedge Pressure to aid clinicians in managing heart failure patients across care settings.
Explore Cardiosense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.